The latter further directly suppresses the expression of C-Myc, a key oncogenic transcription factor inducing the pathogenesis of tumours [15,16], participating in the inhibition of CCDC19-mediated cell cycle transition and the growth of NSCLC. This evidence concerns the gene MYC and neoplasm.